financetom
Business
financetom
/
Business
/
Minsud Releases Maiden Mineral Resource Estimate for Chinchillones Complex in Argentina
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Minsud Releases Maiden Mineral Resource Estimate for Chinchillones Complex in Argentina
Jan 20, 2025 3:50 AM

06:20 AM EST, 01/20/2025 (MT Newswires) -- Minsud Resources ( MDSQF ) late on Friday said it has completed a maiden, pit-constrained mineral resource estimate for the Chinchillones Complex deposit at the Chita Valley project in Argentina.

The mineral resource estimate yielded indicated resources of 188 million tonnes at 0.41% copper equivalent, 0.25% copper, 0.11 grams per tonne (g/t) gold, 10.6 g/t silver, 36 parts per million (ppm) molybdenum and 0.16% zinc, containing 776,000 tonnes of copper equivalent, 466,000 tonnes of copper, 674,000 ounces of gold, 63.5 million ounces of silver, 6,800 tonnes of molybdenum and 291,000 tonnes of zinc.

Inferred resources were 573 million tonnes at 0.36% copper equivalent, 0.22% copper, 0.09 g/t gold, 9 g/t silver, 93 ppm molybdenum and 0.11% zinc, containing 2 million tonnes of copper equivalent, 1.2 million tonnes of copper, 1.7 million ounces of zinc, 165.6 million ounces of silver, 53,200 tonnes of molybdenum and 616,000 tonnes of zinc.

The resources are considered suitable for open-pit mining and the use of the flotation process. Copper, silver and gold are the primary contributors to the mineral resource estimate. Mineralization remains open at depth, with further molybdenum potential identified in unexplored areas.

Minera Sud Argentina, a joint venture between a South32 subsidiary at 50.1% and Minsud at 49.9%, has led exploration at the Chinchillones Complex since 2019.

Minsud's share price gained 3.1% to $1.00 on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
'Squid Game' stars confident South Korea will overcome martial law turmoil
'Squid Game' stars confident South Korea will overcome martial law turmoil
Dec 9, 2024
SEOUL, Dec 9 (Reuters) - Stars of Netflix's ( NFLX ) mega-hit series Squid Game on Monday lamented South Korea's ongoing political turmoil since last week's shocking martial law order by President Yoon Suk Yeol but said they were confident the country will overcome the crisis. The show's highly anticipated second season premiered in Seoul ahead of its release on...
Former Russian ASML employee charged with IP theft and sanctions violations
Former Russian ASML employee charged with IP theft and sanctions violations
Dec 9, 2024
* 43-year-old suspect charged with theft, violating sanctions on Russia * Suspect's custody extended until February * Said to have sold sensitive documents to Russian state-owned companies (Rewrites with court hearing throughout) By Toby Sterling ROTTERDAM, Dec 9 (Reuters) - A Dutch court on Monday extended the detention of a Russian former employee of semiconductor equipment maker ASML suspected of...
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Dec 9, 2024
(Adds: Revance Therapeutics ( RVNC ), Enterprise Bancorp ( EBTC ), Novolex, Arthur J Gallagher ( AJG ), Dow Updates: Omnicom Group ( OMC )) Dec 9 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Monday: ** Anti-wrinkle injection maker Revance Therapeutics ( RVNC ) has agreed to be bought for $3.10 per...
Olema Pharmaceuticals Cleared to Begin Testing Prospective Breast Cancer Candidate
Olema Pharmaceuticals Cleared to Begin Testing Prospective Breast Cancer Candidate
Dec 9, 2024
09:40 AM EST, 12/09/2024 (MT Newswires) -- Olema Pharmaceuticals ( OLMA ) early Monday said the US Food and Drug Administration has cleared the investigational new drug application for the company's OP-3136 drug candidate to treat breast and other types of cancer. The company is expecting to begin phase 1 testing of OP-3136 early in 2025, Olema said. Price: 10.51,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved